Partnering and Investors
Bantam has a unique opportunity to provide meaningful benefits to cancer patients with significant unmet needs.
We are seeking partners and investors to join us as we progress our lead candidate BTM-3566 into clinical trials, expand into new indications and discover additional novel drugs.
Get in touch to learn more and speak with one of our team.
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology.
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need